Evidence Piling NVIDIA's Chip: Is Dominance Ending?
NVIDIA led the AI chip boom, but growing competition and supply forces may erode its edge. This guide breaks down the...
Ways To Enhance Stock Market Returns
Enhancing your stock market returns requires strategic approaches. Learn effective ways to boost your profits and investment success.
27,848 articles
Qualcomm Jumps, Micron Pops as AI Chip Rally Surges
Qualcomm and Micron lead another leg higher in the AI semiconductor rally, as data center demand and memory tightness...
Alex Karp Claims Palantir’s Results Dwarf Software History
Palantir delivers a strong Q1, beating expectations with better profitability than many software peers, yet the stock...
America's Biggest Banks Report: What Investors Watch
Five of america's biggest banks kick off a pivotal earnings week. Here's what to watch as each reports and how the re...
Live: Will Oklo Smash Q1 Earnings Tonight, Market Reacts
Oklo faces a pivotal Q1 2026 earnings night as it pivots from regulatory progress to early commercial milestones. Wat...
Can’t Stop Buying Amazon Stock, Investor Conviction Grows
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
QuantumScape Climbs Eagle Line Milestone
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...
Three EV Stocks Worth the Risk to Buy This July 2026
July 2026 brings oil swings and EV demand shifts, narrowing the window for bold bets. A trio—Tesla, Rivian, and NIO—c...
Riskified (RSKD) 2026 Earnings: Key Takeaways for Investors
This article breaks down riskified (rskd) 2026 earnings, explaining what the latest results mean for growth, profitab...
Cisco’s Critical Infrastructure Era Drives Record Earnings
Cisco beat estimates on a robust AI infrastructure push, delivering record revenue and higher AI targets as the stock...
Cramer Says Nvidia Valuation Outshines China Bets Today
As AI demand accelerates, Nvidia stands out on a growth-adjusted valuation. Cramer argues the stock is cheaper than p...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status